Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Queensland Health
Accenture
Boehringer Ingelheim
McKinsey
Citi
Colorcon
Deloitte
Fish and Richardson

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088831

« Back to Dashboard

NDA 088831 describes PHRENILIN FORTE, which is a drug marketed by Valeant and is included in one NDA. Additional details are available on the PHRENILIN FORTE profile page.

The generic ingredient in PHRENILIN FORTE is acetaminophen; butalbital. There are sixty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital profile page.
Summary for 088831
Tradename:PHRENILIN FORTE
Applicant:Valeant
Ingredient:acetaminophen; butalbital
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength650MG;50MG
Approval Date:Jun 19, 1985TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Daiichi Sankyo
McKinsey
Julphar
Moodys
Novartis
Boehringer Ingelheim
Express Scripts
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot